• NEWS
  • EVENTS and PRESENTATIONS
    • EEVENTS
    • PRESENTATIONS
  • FINANCIALS
    • SEC FILINGS
    • QUARTERLY REPORTS
    • FINANCIAL FUNDIMENTALS
  • ANNUAL REPORTS
  • STOCK
    • STOCK QUOTE AND CHART
    • HISTORIC PRICE LOOKUP
    • INVESTMENT CALCULATOR
    • DIVIDEND HISTORY
    • ANALYST COVERAGE
  • ESG
    • COMMUNITIES
    • INTEGRITY and COMPLIANCE
    • SUSTAINABILITY
    • HSE and REMEDIATION
    • INCLUSION and DIVERSITY
    • POLITICAL CONTRIBUTIONS
    • ESG INFORMATION
  • GOVERNANCE
    • GOVERNANCE OVERVIEW
    • ANNUAL MEETING
    • BOARD OF DIRECTORS
    • COMMITTEE COMPOSITION
    • LEADERSHIP
  • INVESTOR RESOURCES
    • EMAIL ALERTS
    • CONTACT US
    • ONLINE INVESTOR KIT
    • SHAREOWNER SERVICES
    • GLOSSERY
Cognos Therapeutics
  • ABOUT
    • MISSION
    • BOARD of DIRECTORS
    • MANAGEMENT TEAM
    • IP MANAGEMENT
    • CLINICAL ADVISORY BOARD
    • REGULATORY AND COMPLIANCE
  • CLINICAL RELEVANCE
    • FOURTH MODALITY
  • PUBLICATIONS
  • NEWS
  • SHAREHOLDER PORTAL
    • SHAREHOLDER INFORMATION
  • CONTACT
Select Page

Logowithtagline.compress.gd

by cognosadminteam | Jan 12, 2018 | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent Posts

  • Nocturne Acquisition Engages Chardan As Capital Markets Advisor for Cognos Acquisition
  • Nocturne Acquisition Files S-4 In Advance Of Cognos’ NASDAQ Listing
  • Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq
  • Labroot’s Report Focuses on the Need To Develop Better Methods To Deliver Therapeutics to the Brain
  • Cognos Co-Founder and CIO Josh Shachar Discusses The Evolution of the Cognos Vision

Recent Comments

    Archives

    • September 2023
    • August 2023
    • January 2023
    • January 2022
    • November 2021
    • October 2021
    • February 2019
    • January 2018
    • July 2017
    • September 2016
    • March 2015

    Categories

    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Cognos Therapeutics, Inc.

    10604 S La Cienega Blvd.
    Inglewood, CA 90304
    T: 310-641-2700
    E: info@cognosthx.com

    ADDITIONAL INFO

    Privacy Policy
    Terms of Use
    • Facebook
    • X
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress